HCG on a Steroid Cycle and During PCT: How Human Chorionic Gonadotropin Prevents Testicular Atrophy and Speeds Recovery

Your testes do not wait patiently for you to finish your cycle. From the first week of exogenous androgen use, LH drops to near zero, intratesticular testosterone collapses, and the Leydig cells that produce your natural testosterone begin to atrophy. By the time you reach PCT, you are asking shrunken, dormant cells to restart production on command, and the results are predictably slow. HCG changes this equation entirely. Used during the cycle rather than after it, HCG on a steroid cycle keeps the Leydig cells active and the testes functional throughout suppression, so that when PCT begins, the machinery is already running. Hemi Pharma UK stocks pharmaceutical-grade HCG with full Janoshik verification, and this article explains exactly how to use it.

What is HCG and how does it mimic LH in the testes?

Human chorionic gonadotropin is a glycoprotein hormone naturally produced by the placenta during pregnancy. Its alpha subunit is structurally identical to the alpha subunit of LH, FSH, and TSH. Its beta subunit is highly homologous to the beta subunit of LH, which is why HCG binds to the LH/CG receptor on Leydig cells with high affinity and triggers the same intracellular signalling cascade that LH does: activation of adenylyl cyclase, elevation of cyclic AMP, and stimulation of the steroidogenic enzymes (StAR protein, CYP11A1, CYP17A1, 3β-HSD, 17β-HSD) that convert cholesterol into testosterone.

The practical consequence is simple. When your pituitary stops producing LH because exogenous androgens have shut down the HPTA, HCG can replace that missing LH signal at the testicular level. The Leydig cells do not distinguish between pituitary LH and injected HCG: they receive the same receptor activation, produce testosterone through the same enzymatic pathway, and maintain their functional capacity rather than atrophying from disuse.

Why does intratesticular testosterone matter separately from blood testosterone?

This is the distinction that most steroid users miss, and it is the entire reason HCG exists as a cycle adjunct. When you inject Testosterone Enanthate, your serum (blood) testosterone rises to supraphysiological levels. But the testosterone inside your testes, called intratesticular testosterone (ITT), collapses to near zero because the Leydig cells have stopped producing it. These are two completely separate pools.

ITT matters because spermatogenesis requires intratesticular testosterone concentrations that are 50 to 100 times higher than serum levels. The Sertoli cells that nurse developing sperm through their 74-day maturation cycle need this massively concentrated local testosterone to function. Serum testosterone, no matter how high, cannot substitute for local production: the blood-testis barrier prevents circulating testosterone from reaching the seminiferous tubules at the concentrations required.

The landmark Coviello et al. study published in the Journal of Clinical Endocrinology and Metabolism demonstrated this directly. In healthy men with testosterone-induced gonadotropin suppression, low-dose HCG (250 IU every other day) maintained intratesticular testosterone at approximately 25% of baseline, compared to a near-total collapse in men not receiving HCG. Higher HCG doses (500 IU every other day) maintained ITT at approximately 75% of baseline. The study established that even low-dose HCG prevents the catastrophic ITT decline that makes post-cycle recovery so difficult.

Does HCG on cycle actually preserve spermatogenesis?

Yes. A retrospective study by Hsieh and colleagues published in the Journal of Urology examined hypogonadal men receiving testosterone replacement therapy with concomitant low-dose HCG (500 IU every other day, administered intramuscularly). No patient became azoospermic during combined therapy. The authors concluded that concurrent testosterone and HCG use may preserve fertility in men who require testosterone replacement but wish to maintain reproductive potential.

This finding has significant practical implications for steroid users who want children, either now or in the future. Without HCG, a standard steroid cycle drives sperm count towards zero within 8 to 12 weeks. With on-cycle HCG, spermatogenesis is maintained or at least partially preserved, dramatically shortening the timeline to fertility recovery after the cycle ends. For men where fertility preservation is a priority, on-cycle HCG is not optional; it is essential.

What is the correct HCG dosing protocol during a steroid cycle?

The on-cycle HCG protocol that balances Leydig cell maintenance with LH receptor sensitivity is 250 IU to 500 IU, administered subcutaneously or intramuscularly, twice per week throughout the cycle. This dosing range is derived directly from the Coviello ITT data: 250 IU every other day (roughly 875 IU per week) maintained ITT at 25% of baseline, and 500 IU every other day (roughly 1750 IU per week) maintained ITT at 75%. Most practical protocols split the difference at 500 IU to 1000 IU per week, divided into two injections.

The twice-weekly schedule maintains consistent Leydig cell stimulation without the peaks and troughs that come from less frequent, larger doses. HCG has a half-life of approximately 24 to 36 hours, so twice-weekly injection provides relatively stable stimulation.

Some users inject HCG on the same days as their testosterone injections for convenience. Others prefer to stagger them. There is no clinical evidence favouring either approach; consistency matters more than specific injection days.

HCG use should continue throughout the entire cycle, beginning in the first week and ending when the exogenous androgens are discontinued. If you are running a cycle with Testosterone Cypionate or Enanthate, HCG continues until the last injection. During the ester clearance window (the 14 days between the last injection and the start of SERM therapy), HCG can be continued at the same dose or modestly increased to bridge the gap before the SERM takes over gonadotropin stimulation.

Why is on-cycle HCG better than post-cycle HCG?

The older approach to HCG use was to administer it during PCT, often at high doses (2000 to 5000 IU every other day for 2 to 3 weeks), as a “blast” to restart testicular function before introducing the SERM. This approach has largely fallen out of favour for two reasons.

First, high-dose HCG can desensitise the LH receptor. The LH/CG receptor is subject to downregulation when exposed to sustained high-level stimulation: the cell internalises receptors, reduces receptor density on the cell surface, and becomes progressively less responsive to further stimulation. This is the opposite of what you want during recovery. By the time the SERM kicks in and natural LH starts rising, the Leydig cells may be temporarily refractory because the high-dose HCG has desensitised them.

Second, high-dose HCG aromatises. HCG-stimulated testosterone production in the testes means more local substrate for aromatisation, and at high doses, oestradiol can rise significantly. Elevated oestrogen during PCT counteracts the SERM’s anti-oestrogenic effect at the pituitary, potentially undermining the very recovery the protocol is designed to achieve.

On-cycle HCG at low to moderate doses avoids both problems. The Leydig cells receive consistent, gentle stimulation that maintains function without driving receptor downregulation. The oestrogen contribution from intratesticular aromatisation at 500 IU twice weekly is modest and manageable. And when PCT begins, the testes are already functional, meaning the SERM’s stimulation of LH finds responsive, non-atrophied Leydig cells ready to resume full production.

How do you reconstitute and store HCG?

HCG is supplied as a lyophilised (freeze-dried) powder that must be reconstituted with bacteriostatic water before use. This is not optional: HCG in powder form is stable at room temperature, but once reconstituted, it is a protein in solution that degrades over time and must be refrigerated.

To reconstitute: draw the desired volume of bacteriostatic water (typically 1ml to 2ml, depending on your preferred concentration) into a syringe. Inject it slowly down the inside wall of the HCG vial, not directly onto the powder. Allow the water to dissolve the powder by gentle swirling, not shaking (vigorous shaking can denature the protein). The solution should be clear; if it is cloudy or contains particulates, do not use it.

Once reconstituted, HCG must be stored in the refrigerator (2 to 8 degrees Celsius) and used within 60 days. Bacteriostatic water contains benzyl alcohol as a preservative, which prevents bacterial growth in the multi-use vial. Do not use sterile water (which lacks the preservative) unless you plan to use the entire vial in a single session, which is impractical for the twice-weekly on-cycle protocol.

For injection, HCG is typically administered subcutaneously using an insulin syringe (29 to 31 gauge, 0.5-inch needle) into the abdominal fat or thigh. Subcutaneous injection is well-absorbed and substantially less painful than intramuscular injection for the small volumes involved (0.1ml to 0.25ml per injection at typical reconstitution concentrations).

What are the side effects of HCG?

At the low doses used for on-cycle Leydig cell maintenance (250 to 500 IU twice weekly), side effects are minimal. The most common is a mild increase in oestradiol from intratesticular aromatisation, which is usually clinically insignificant and does not require additional AI dosing beyond what the cycle already demands. If you are already managing oestrogen with Anastrozole as part of your cycle protocol, the HCG contribution to oestrogen is absorbed within the existing management framework.

At higher doses (1500 to 5000 IU, as in the older post-cycle blast protocols), side effects become more relevant: significant oestradiol elevation, water retention, mood changes related to the oestrogen spike, and the LH receptor desensitisation discussed above. This is why the high-dose approach has been abandoned by most informed practitioners.

Injection site reactions (minor redness, swelling) are occasionally reported but are typically related to technique rather than the drug itself. Using an appropriately sized insulin syringe and rotating injection sites prevents most local reactions.

Do you need HCG if your cycle is short or mild?

The argument for skipping HCG on a short, mild cycle (for example, an 8-week Anavar cycle at moderate doses) is that HPTA suppression is less severe and recovery will be faster regardless. This is partially true: a short, mild cycle does produce less suppression than a 16-week multi-compound cycle, and recovery without HCG may be adequate.

However, testicular atrophy begins within the first 2 to 3 weeks of any HPTA-suppressive cycle, including mild ones. The Leydig cells do not wait for severe suppression before they start shrinking. If you want the fastest, most complete recovery possible, on-cycle HCG provides it regardless of cycle intensity. For users running longer cycles or cycles involving 19-nor compounds like Nandrolone Decanoate or Trenbolone Enanthate, on-cycle HCG is not a luxury but a necessity: the extended HPTA suppression from 19-nor metabolites makes recovery without maintained Leydig cell function significantly harder, as explained in our Nolvadex vs Clomid comparison.

How does HCG fit into the complete cycle and PCT timeline?

A properly structured cycle with HCG integration follows this sequence:

Weeks 1 through end of cycle: inject your chosen androgen(s) per protocol. Simultaneously inject HCG 250 to 500 IU twice weekly. Manage oestrogen with an AI if indicated by bloodwork.

Ester clearance window (e.g. 14 days after last injection of Testosterone Enanthate): continue HCG at the same dose or increase slightly (500 IU every other day). This bridges the gap between the last androgen injection and the start of SERM therapy, keeping the Leydig cells stimulated while the ester clears.

PCT start: discontinue HCG. Begin Tamoxifen 20mg daily (or Clomiphene 50mg daily) for 4 to 6 weeks. The SERM takes over the job of stimulating LH and FSH release from the pituitary. Because the Leydig cells have been maintained with HCG, they respond quickly to the rising LH, and testosterone recovery is faster and more complete than in users who did not use on-cycle HCG.

Post-PCT bloodwork at 4 to 6 weeks and 10 to 12 weeks confirms recovery, as detailed in our PCT complete guide.

For verified, independently tested HCG with published Janoshik lab results, Hemi Pharma HCG is available with full product verification.

Frequently Asked Questions

Can HCG be used as a testosterone booster without steroids?

Yes. HCG monotherapy (500 IU to 1500 IU twice weekly) is used clinically as an alternative to TRT for men with secondary hypogonadism. Because it stimulates endogenous testosterone production rather than replacing it, it maintains fertility and testicular size. However, it is not as effective at raising testosterone as exogenous testosterone replacement, and it requires regular injections. It is most appropriate for hypogonadal men who prioritise fertility preservation over maximum testosterone elevation.

Does HCG cause gynaecomastia?

At the low doses used on-cycle (250 to 500 IU twice weekly), the oestrogen contribution is minimal and rarely causes gynaecomastia independently. At higher doses (2000 to 5000 IU), the intratesticular testosterone production is sufficient to generate meaningful oestradiol via aromatisation, which can contribute to gynaecomastia. This is another reason to favour low-dose on-cycle use over high-dose PCT blasts. If you are already managing oestrogen with Anastrozole, the small additional oestrogen from on-cycle HCG is typically covered by your existing AI dosing. Our side effects guide covers gynaecomastia prevention in detail.

Is HCG the same as HMG?

No. HCG mimics LH and stimulates testosterone production. HMG (human menopausal gonadotropin) contains both LH activity and FSH activity, directly stimulating both Leydig cells and Sertoli cells. HMG is sometimes used alongside HCG in fertility protocols where FSH stimulation is needed to jumpstart spermatogenesis. For standard on-cycle testicular maintenance, HCG alone is sufficient because the primary goal is maintaining Leydig cell function and intratesticular testosterone.

Can you use HCG on a cycle with Nandrolone or Trenbolone?

Yes, and you should. 19-nor compounds produce the deepest and most prolonged HPTA suppression of any steroid class, with metabolites that continue suppressing the axis for months after the parent compound clears. On-cycle HCG is especially important with these compounds because Leydig cells that have been maintained throughout a Nandrolone or Trenbolone cycle recover far more quickly than cells that have been atrophied and dormant for 14 to 16 weeks of total suppression.

How long does a vial of reconstituted HCG last?

When reconstituted with bacteriostatic water and stored in the refrigerator at 2 to 8 degrees Celsius, HCG remains stable for approximately 60 days. After 60 days, potency may decline and the risk of bacterial contamination increases even with the preservative. If reconstituted with sterile water (no preservative), it should be used within 48 hours. Always use bacteriostatic water for multi-use vials.

References

Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005;90(5):2595-2602. PubMed 15713727

Hsieh TC, Pastuszak AW, Hwang K, et al. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647-650. PubMed 23260550

Lee JA, Ramasamy R. Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men. Transl Androl Urol. 2018;7(Suppl 3):S348-S352. TAU 19649

Shopping Basket
Scroll to Top